 | • レポートコード：QFJ1-4596 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、新規抗ウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、免疫系モジュレーター、その他）、用途別市場規模（肝炎治療、HIV/AIDS治療、ヘルペス治療、インフルエンザ治療、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・新規抗ウイルス薬の市場動向 ・企業の競争状況、市場シェア ・新規抗ウイルス薬の種類別市場規模と予測2016-2027（逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、免疫系モジュレーター、その他） ・新規抗ウイルス薬の用途別市場規模と予測2016-2027（肝炎治療、HIV/AIDS治療、ヘルペス治療、インフルエンザ治療、その他） ・新規抗ウイルス薬の北米市場規模2016-2027（アメリカ、カナダ） ・新規抗ウイルス薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・新規抗ウイルス薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・新規抗ウイルス薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・新規抗ウイルス薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche Holding AG、GlaxoSmithKline、Bristol-Myers Squibb、AbbVie、Johnson & Johnson、Merck & Co、Novartis、Dr Reddy’s、Gilead Sciences、Aurobindo Pharma、Cipla） ・結論 |
The mechanism of action of antiviral drugs is mainly to inhibit the entry of viral particles into host cells and to inhibit the early stages of viral replication. There is also an inhibitor of DNA polymerase, which is mainly due to its ability to inhibit viral coding. At present, new antiviral drugs are actively seeking host factors, both in the initial stage of viral infection and in the later stages of nuclear transport of viral RNP complexes, to produce new drugs with new modes of action without drug resistance.
Market Analysis and Insights: Global Novel Antiviral Drugs Market
The global Novel Antiviral Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Novel Antiviral Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Novel Antiviral Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Novel Antiviral Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Novel Antiviral Drugs market.
Global Novel Antiviral Drugs Scope and Market Size
Novel Antiviral Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Novel Antiviral Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Immune System Modulators
Other
Segment by Application
Hepatitis Therapeutics
HIV/AIDS Therapeutics
Herpes Therapeutics
Influenza Therapeutics
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche Holding AG
GlaxoSmithKline
Bristol-Myers Squibb
AbbVie
Johnson & Johnson
Merck & Co
Novartis
Dr Reddy’s
Gilead Sciences
Aurobindo Pharma
Cipla
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Novel Antiviral Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Reverse Transcriptase Inhibitors
1.2.3 Protease Inhibitors
1.2.4 Fusion Inhibitors
1.2.5 Immune System Modulators
1.2.6 Other
1.3 Market by Application
1.3.1 Global Novel Antiviral Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hepatitis Therapeutics
1.3.3 HIV/AIDS Therapeutics
1.3.4 Herpes Therapeutics
1.3.5 Influenza Therapeutics
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Novel Antiviral Drugs Market Perspective (2016-2027)
2.2 Novel Antiviral Drugs Growth Trends by Regions
2.2.1 Novel Antiviral Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Novel Antiviral Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Novel Antiviral Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Novel Antiviral Drugs Industry Dynamic
2.3.1 Novel Antiviral Drugs Market Trends
2.3.2 Novel Antiviral Drugs Market Drivers
2.3.3 Novel Antiviral Drugs Market Challenges
2.3.4 Novel Antiviral Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Novel Antiviral Drugs Players by Revenue
3.1.1 Global Top Novel Antiviral Drugs Players by Revenue (2016-2021)
3.1.2 Global Novel Antiviral Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Novel Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Novel Antiviral Drugs Revenue
3.4 Global Novel Antiviral Drugs Market Concentration Ratio
3.4.1 Global Novel Antiviral Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Novel Antiviral Drugs Revenue in 2020
3.5 Novel Antiviral Drugs Key Players Head office and Area Served
3.6 Key Players Novel Antiviral Drugs Product Solution and Service
3.7 Date of Enter into Novel Antiviral Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Novel Antiviral Drugs Breakdown Data by Type
4.1 Global Novel Antiviral Drugs Historic Market Size by Type (2016-2021)
4.2 Global Novel Antiviral Drugs Forecasted Market Size by Type (2022-2027)
5 Novel Antiviral Drugs Breakdown Data by Application
5.1 Global Novel Antiviral Drugs Historic Market Size by Application (2016-2021)
5.2 Global Novel Antiviral Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Novel Antiviral Drugs Market Size (2016-2027)
6.2 North America Novel Antiviral Drugs Market Size by Type
6.2.1 North America Novel Antiviral Drugs Market Size by Type (2016-2021)
6.2.2 North America Novel Antiviral Drugs Market Size by Type (2022-2027)
6.2.3 North America Novel Antiviral Drugs Market Size by Type (2016-2027)
6.3 North America Novel Antiviral Drugs Market Size by Application
6.3.1 North America Novel Antiviral Drugs Market Size by Application (2016-2021)
6.3.2 North America Novel Antiviral Drugs Market Size by Application (2022-2027)
6.3.3 North America Novel Antiviral Drugs Market Size by Application (2016-2027)
6.4 North America Novel Antiviral Drugs Market Size by Country
6.4.1 North America Novel Antiviral Drugs Market Size by Country (2016-2021)
6.4.2 North America Novel Antiviral Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Novel Antiviral Drugs Market Size (2016-2027)
7.2 Europe Novel Antiviral Drugs Market Size by Type
7.2.1 Europe Novel Antiviral Drugs Market Size by Type (2016-2021)
7.2.2 Europe Novel Antiviral Drugs Market Size by Type (2022-2027)
7.2.3 Europe Novel Antiviral Drugs Market Size by Type (2016-2027)
7.3 Europe Novel Antiviral Drugs Market Size by Application
7.3.1 Europe Novel Antiviral Drugs Market Size by Application (2016-2021)
7.3.2 Europe Novel Antiviral Drugs Market Size by Application (2022-2027)
7.3.3 Europe Novel Antiviral Drugs Market Size by Application (2016-2027)
7.4 Europe Novel Antiviral Drugs Market Size by Country
7.4.1 Europe Novel Antiviral Drugs Market Size by Country (2016-2021)
7.4.2 Europe Novel Antiviral Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Novel Antiviral Drugs Market Size (2016-2027)
8.2 Asia-Pacific Novel Antiviral Drugs Market Size by Type
8.2.1 Asia-Pacific Novel Antiviral Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Novel Antiviral Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Novel Antiviral Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Novel Antiviral Drugs Market Size by Application
8.3.1 Asia-Pacific Novel Antiviral Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Novel Antiviral Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Novel Antiviral Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Novel Antiviral Drugs Market Size by Region
8.4.1 Asia-Pacific Novel Antiviral Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Novel Antiviral Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Novel Antiviral Drugs Market Size (2016-2027)
9.2 Latin America Novel Antiviral Drugs Market Size by Type
9.2.1 Latin America Novel Antiviral Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Novel Antiviral Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Novel Antiviral Drugs Market Size by Type (2016-2027)
9.3 Latin America Novel Antiviral Drugs Market Size by Application
9.3.1 Latin America Novel Antiviral Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Novel Antiviral Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Novel Antiviral Drugs Market Size by Application (2016-2027)
9.4 Latin America Novel Antiviral Drugs Market Size by Country
9.4.1 Latin America Novel Antiviral Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Novel Antiviral Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Novel Antiviral Drugs Market Size (2016-2027)
10.2 Middle East & Africa Novel Antiviral Drugs Market Size by Type
10.2.1 Middle East & Africa Novel Antiviral Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Novel Antiviral Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Novel Antiviral Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Novel Antiviral Drugs Market Size by Application
10.3.1 Middle East & Africa Novel Antiviral Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Novel Antiviral Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Novel Antiviral Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Novel Antiviral Drugs Market Size by Country
10.4.1 Middle East & Africa Novel Antiviral Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Novel Antiviral Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche Holding AG
11.1.1 Roche Holding AG Company Details
11.1.2 Roche Holding AG Business Overview
11.1.3 Roche Holding AG Novel Antiviral Drugs Introduction
11.1.4 Roche Holding AG Revenue in Novel Antiviral Drugs Business (2016-2021)
11.1.5 Roche Holding AG Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Novel Antiviral Drugs Introduction
11.2.4 GlaxoSmithKline Revenue in Novel Antiviral Drugs Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Novel Antiviral Drugs Introduction
11.3.4 Bristol-Myers Squibb Revenue in Novel Antiviral Drugs Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Novel Antiviral Drugs Introduction
11.4.4 AbbVie Revenue in Novel Antiviral Drugs Business (2016-2021)
11.4.5 AbbVie Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Novel Antiviral Drugs Introduction
11.5.4 Johnson & Johnson Revenue in Novel Antiviral Drugs Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 Merck & Co
11.6.1 Merck & Co Company Details
11.6.2 Merck & Co Business Overview
11.6.3 Merck & Co Novel Antiviral Drugs Introduction
11.6.4 Merck & Co Revenue in Novel Antiviral Drugs Business (2016-2021)
11.6.5 Merck & Co Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Novel Antiviral Drugs Introduction
11.7.4 Novartis Revenue in Novel Antiviral Drugs Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Dr Reddy’s
11.8.1 Dr Reddy’s Company Details
11.8.2 Dr Reddy’s Business Overview
11.8.3 Dr Reddy’s Novel Antiviral Drugs Introduction
11.8.4 Dr Reddy’s Revenue in Novel Antiviral Drugs Business (2016-2021)
11.8.5 Dr Reddy’s Recent Development
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Details
11.9.2 Gilead Sciences Business Overview
11.9.3 Gilead Sciences Novel Antiviral Drugs Introduction
11.9.4 Gilead Sciences Revenue in Novel Antiviral Drugs Business (2016-2021)
11.9.5 Gilead Sciences Recent Development
11.10 Aurobindo Pharma
11.10.1 Aurobindo Pharma Company Details
11.10.2 Aurobindo Pharma Business Overview
11.10.3 Aurobindo Pharma Novel Antiviral Drugs Introduction
11.10.4 Aurobindo Pharma Revenue in Novel Antiviral Drugs Business (2016-2021)
11.10.5 Aurobindo Pharma Recent Development
11.11 Cipla
11.11.1 Cipla Company Details
11.11.2 Cipla Business Overview
11.11.3 Cipla Novel Antiviral Drugs Introduction
11.11.4 Cipla Revenue in Novel Antiviral Drugs Business (2016-2021)
11.11.5 Cipla Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Novel Antiviral Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Reverse Transcriptase Inhibitors
Table 3. Key Players of Protease Inhibitors
Table 4. Key Players of Fusion Inhibitors
Table 5. Key Players of Immune System Modulators
Table 6. Key Players of Other
Table 7. Global Novel Antiviral Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Novel Antiviral Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Novel Antiviral Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Novel Antiviral Drugs Market Share by Regions (2016-2021)
Table 11. Global Novel Antiviral Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Novel Antiviral Drugs Market Share by Regions (2022-2027)
Table 13. Novel Antiviral Drugs Market Trends
Table 14. Novel Antiviral Drugs Market Drivers
Table 15. Novel Antiviral Drugs Market Challenges
Table 16. Novel Antiviral Drugs Market Restraints
Table 17. Global Novel Antiviral Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Novel Antiviral Drugs Market Share by Players (2016-2021)
Table 19. Global Top Novel Antiviral Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Novel Antiviral Drugs as of 2020)
Table 20. Ranking of Global Top Novel Antiviral Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Novel Antiviral Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Novel Antiviral Drugs Product Solution and Service
Table 24. Date of Enter into Novel Antiviral Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Novel Antiviral Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Novel Antiviral Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Novel Antiviral Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Novel Antiviral Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Novel Antiviral Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Novel Antiviral Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Novel Antiviral Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Novel Antiviral Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Novel Antiviral Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Novel Antiviral Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Novel Antiviral Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Novel Antiviral Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Novel Antiviral Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Novel Antiviral Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Novel Antiviral Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Novel Antiviral Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Novel Antiviral Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Novel Antiviral Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Novel Antiviral Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Novel Antiviral Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Novel Antiviral Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Novel Antiviral Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Novel Antiviral Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Novel Antiviral Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Novel Antiviral Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Novel Antiviral Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Novel Antiviral Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Novel Antiviral Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Novel Antiviral Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Novel Antiviral Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Novel Antiviral Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Novel Antiviral Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Novel Antiviral Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Novel Antiviral Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Novel Antiviral Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Novel Antiviral Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Novel Antiviral Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Novel Antiviral Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. Roche Holding AG Company Details
Table 65. Roche Holding AG Business Overview
Table 66. Roche Holding AG Novel Antiviral Drugs Product
Table 67. Roche Holding AG Revenue in Novel Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 68. Roche Holding AG Recent Development
Table 69. GlaxoSmithKline Company Details
Table 70. GlaxoSmithKline Business Overview
Table 71. GlaxoSmithKline Novel Antiviral Drugs Product
Table 72. GlaxoSmithKline Revenue in Novel Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 73. GlaxoSmithKline Recent Development
Table 74. Bristol-Myers Squibb Company Details
Table 75. Bristol-Myers Squibb Business Overview
Table 76. Bristol-Myers Squibb Novel Antiviral Drugs Product
Table 77. Bristol-Myers Squibb Revenue in Novel Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 78. Bristol-Myers Squibb Recent Development
Table 79. AbbVie Company Details
Table 80. AbbVie Business Overview
Table 81. AbbVie Novel Antiviral Drugs Product
Table 82. AbbVie Revenue in Novel Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 83. AbbVie Recent Development
Table 84. Johnson & Johnson Company Details
Table 85. Johnson & Johnson Business Overview
Table 86. Johnson & Johnson Novel Antiviral Drugs Product
Table 87. Johnson & Johnson Revenue in Novel Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 88. Johnson & Johnson Recent Development
Table 89. Merck & Co Company Details
Table 90. Merck & Co Business Overview
Table 91. Merck & Co Novel Antiviral Drugs Product
Table 92. Merck & Co Revenue in Novel Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 93. Merck & Co Recent Development
Table 94. Novartis Company Details
Table 95. Novartis Business Overview
Table 96. Novartis Novel Antiviral Drugs Product
Table 97. Novartis Revenue in Novel Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 98. Novartis Recent Development
Table 99. Dr Reddy’s Company Details
Table 100. Dr Reddy’s Business Overview
Table 101. Dr Reddy’s Revenue in Novel Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 102. Dr Reddy’s Recent Development
Table 103. Gilead Sciences Company Details
Table 104. Gilead Sciences Business Overview
Table 105. Gilead Sciences Novel Antiviral Drugs Product
Table 106. Gilead Sciences Revenue in Novel Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 107. Gilead Sciences Recent Development
Table 108. Aurobindo Pharma Company Details
Table 109. Aurobindo Pharma Business Overview
Table 110. Aurobindo Pharma Novel Antiviral Drugs Product
Table 111. Aurobindo Pharma Revenue in Novel Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 112. Aurobindo Pharma Recent Development
Table 113. Cipla Company Details
Table 114. Cipla Business Overview
Table 115. Cipla Novel Antiviral Drugs Product
Table 116. Cipla Revenue in Novel Antiviral Drugs Business (2016-2021) & (US$ Million)
Table 117. Cipla Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Novel Antiviral Drugs Market Share by Type: 2020 VS 2027
Figure 2. Reverse Transcriptase Inhibitors Features
Figure 3. Protease Inhibitors Features
Figure 4. Fusion Inhibitors Features
Figure 5. Immune System Modulators Features
Figure 6. Other Features
Figure 7. Global Novel Antiviral Drugs Market Share by Application: 2020 VS 2027
Figure 8. Hepatitis Therapeutics Case Studies
Figure 9. HIV/AIDS Therapeutics Case Studies
Figure 10. Herpes Therapeutics Case Studies
Figure 11. Influenza Therapeutics Case Studies
Figure 12. Other Case Studies
Figure 13. Novel Antiviral Drugs Report Years Considered
Figure 14. Global Novel Antiviral Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Novel Antiviral Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Novel Antiviral Drugs Market Share by Regions: 2020 VS 2027
Figure 17. Global Novel Antiviral Drugs Market Share by Regions (2022-2027)
Figure 18. Global Novel Antiviral Drugs Market Share by Players in 2020
Figure 19. Global Top Novel Antiviral Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Novel Antiviral Drugs as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Novel Antiviral Drugs Revenue in 2020
Figure 21. Global Novel Antiviral Drugs Revenue Market Share by Type (2016-2021)
Figure 22. Global Novel Antiviral Drugs Revenue Market Share by Type (2022-2027)
Figure 23. North America Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Novel Antiviral Drugs Market Share by Type (2016-2027)
Figure 25. North America Novel Antiviral Drugs Market Share by Application (2016-2027)
Figure 26. North America Novel Antiviral Drugs Market Share by Country (2016-2027)
Figure 27. United States Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Novel Antiviral Drugs Market Share by Type (2016-2027)
Figure 31. Europe Novel Antiviral Drugs Market Share by Application (2016-2027)
Figure 32. Europe Novel Antiviral Drugs Market Share by Country (2016-2027)
Figure 33. Germany Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Novel Antiviral Drugs Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Novel Antiviral Drugs Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Novel Antiviral Drugs Market Share by Region (2016-2027)
Figure 43. China Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Novel Antiviral Drugs Market Share by Type (2016-2027)
Figure 51. Latin America Novel Antiviral Drugs Market Share by Application (2016-2027)
Figure 52. Latin America Novel Antiviral Drugs Market Share by Country (2016-2027)
Figure 53. Mexico Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Novel Antiviral Drugs Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Novel Antiviral Drugs Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Novel Antiviral Drugs Market Share by Country (2016-2027)
Figure 59. Turkey Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Novel Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Roche Holding AG Revenue Growth Rate in Novel Antiviral Drugs Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Novel Antiviral Drugs Business (2016-2021)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Novel Antiviral Drugs Business (2016-2021)
Figure 65. AbbVie Revenue Growth Rate in Novel Antiviral Drugs Business (2016-2021)
Figure 66. Johnson & Johnson Revenue Growth Rate in Novel Antiviral Drugs Business (2016-2021)
Figure 67. Merck & Co Revenue Growth Rate in Novel Antiviral Drugs Business (2016-2021)
Figure 68. Novartis Revenue Growth Rate in Novel Antiviral Drugs Business (2016-2021)
Figure 69. Dr Reddy’s Revenue Growth Rate in Novel Antiviral Drugs Business (2016-2021)
Figure 70. Gilead Sciences Revenue Growth Rate in Novel Antiviral Drugs Business (2016-2021)
Figure 71. Aurobindo Pharma Revenue Growth Rate in Novel Antiviral Drugs Business (2016-2021)
Figure 72. Cipla Revenue Growth Rate in Novel Antiviral Drugs Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界のインフルエンザ (Flu) 抗ウイルス薬市場規模・現状・予測（2021年-2027年） Antiviral drugs are a class of drugs for the specific treatment of viral infections. Market Analysis and Insights: Global Influenza (Flu) Antiviral Drugs Market The global Influenza (Flu) Antiviral Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR…- 世界の抗ウイルス療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Antiviral Therapeutics Market The global Antiviral Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…
- 世界の直接作用型抗ウイルス薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Direct-acting Antiviral Drugs Market The global Direct-acting Antiviral Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…
- 世界のインフルエンザ用抗ウイルス薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Influenza Antiviral Drugs Market The global Influenza Antiviral Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, th…
- 世界の移植治療薬市場規模・現状・予測（2021年-2027年） Transplantation is the transfer (engraftment) of human cells, tissues, or organs from a donor to a recipient, with the aim of restoring function(s) in the body. Market Analysis and Insights: Global Transplantation Therapeutics Drugs Market The global Transplantation Therapeutics Drugs market size is…